Farther Finance Advisors’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Farther Finance Advisors’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	–	Sell	-14,418	Closed	-$488K	–	6330
2026 Q2	$488K	Buy	14,418 +3,266	+29%	+$109K	﹤0.01%	1577
2026 Q1	$337K	Buy	11,152 +1,468	+15%	+$47.2K	﹤0.01%	1667
2025 Q4	$302K	Buy	9,684 +2,313	+31%	+$57K	﹤0.01%	1640
2025 Q3	$149K	Buy	7,371 +749	+11%	+$13.2K	﹤0.01%	1790
2025 Q2	$111K	Sell	6,622 -118	-2%	-$1.9K	﹤0.01%	1708
2025 Q1	$103K	Buy	6,740 +148	+2%	+$2.64K	﹤0.01%	1534
2024 Q4	$145K	Buy	6,592 +2,054	+45%	+$37.4K	0.01%	1146
2024 Q3	$81.8K	Buy	4,538 +3,323	+273%	+$58.2K	﹤0.01%	1402
2024 Q2	$19.9K	Sell	1,215 -160	-12%	-$2.46K	﹤0.01%	1778
2024 Q1	$19.1K	Buy	1,375 +9	+0.7%	+$113	﹤0.01%	1507
2023 Q4	$14.3K	Buy	1,366 +963	+239%	+$8.99K	﹤0.01%	1454
2023 Q3	$4.11K	Buy	403 +52	+15%	+$484	﹤0.01%	1583
2023 Q2	$2.64K	Buy	351 +156	+80%	+$1.26K	﹤0.01%	1658
2023 Q1	$1.73K	Hold	195	–	–	﹤0.01%	1687
2022 Q4	$1.78K	Buy	+195	New	+$1.7K	﹤0.01%	1493

Other funds holding TEVA

WWM

Whalen Wealth Management Las Vegas, Nevada $234M AUM 28.06% 1-Year Est. Return

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

CAM

Cacti Asset Management Atlanta, Georgia $1.89B AUM 58.55% 1-Year Est. Return

IRC

Investors Research Corp Atlanta, Georgia $569M AUM 15.41% 1-Year Est. Return

VEM

Vann Equity Management Plano, Texas $168M AUM

MPWT

MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return

GWM

Gilpin Wealth Management Denver, Colorado $148M AUM 25.13% 1-Year Est. Return

BAM

Byrne Asset Management Kingston, New Jersey $179M AUM 29.67% 1-Year Est. Return

EWP

Elevation Wealth Partners Santa Rosa, California $356M AUM 17.04% 1-Year Est. Return

AAG

Armstrong Advisory Group Needham, Massachusetts $1.66B AUM 13.15% 1-Year Est. Return

Farther Finance Advisors's TEVA Position: Q3 2026 in Review

Farther Finance Advisors sold out of Teva Pharmaceutical Industries Limited (TEVA) in Q3 2026, closing a stake of 14,418 shares — an estimated $488K sold.

Farther Finance Advisors first reported a position in TEVA in Q4 2022 and held it in 15 quarters. The position peaked at $488K in Q2 2026. 10 funds tracked by Wall St. Rank hold TEVA as of Q3 2026.

Farther Finance Advisors reported no remaining Teva Pharmaceutical Industries Limited position as of Q3 2026 after selling out during the quarter.
Farther Finance Advisors sold 14,418 Teva Pharmaceutical Industries Limited shares in Q3 2026, an estimated $488K.
Farther Finance Advisors first reported a position in Teva Pharmaceutical Industries Limited in Q4 2022 and held it in 15 quarters.
Farther Finance Advisors's Teva Pharmaceutical Industries Limited position peaked at $488K in Q2 2026.
10 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q3 2026.

Based on Farther Finance Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.